查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1247443

2023-2030 年全球藥物管理市場

Global Medication Management Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球藥物管理市場規模預計到 2022 年將達到 246934 萬美元，到 2030 年將達到 1012943 萬美元，預測期內（2023-2030 年）的複合年增長率為 20.00%。預計將在

藥物管理是與患者和護理人員溝通的策略，以創建準確、全面的所有消耗藥物清單。 完整準確的處方清單是解決藥品核對管理問題的第一步。 這些工具可識別可能使患者面臨藥物相關不良事件風險的行為，例如用藥過量或用藥不足、忘記服藥或其他影響依從性的重要背景因素。也有幫助。

市場動態

推動全球藥房管理市場的主要因素是行業參與者推出產品推動市場發展，越來越多的醫院投資於創新技術，隨著全球處方數量的增加，該行業有望快速增長。

市場進入者推出的產品正在推動市場的發展。

對新產品發布的投資增加、醫療保健流程管理的改進以及處方錯誤的減少預計將推動市場擴張。

例如，2023 年 1 月，我們根據某些合同安排合併其財務業績的中國實體之一中新醫療科技（有限公司）（“中新”）推出了“藥物管理支持”微信小程序”（“小程序”）管理癌症患者的各種問題，為癌症和其他重大疾病患者提供服務。它由提供醫療用品的基於平台的互聯網技術公司眾巢公司宣布, Zhongxin 建立了幫助癌症患者導航和克服藥物挑戰的計劃。

2020 年 11 月，位於馬薩諸塞州波士頓的數字治療配套平台 Medisafe 宣布立即實施其革命性的 Medisafe Maestro 平台。 這個最先進的系統可以精確、快速地安排患者的旅程，創建與數字藥物伴侶一起提供的個性化患者護理資源。 Medisafe 通過集成的 Care Connector 為製藥行業提供數字患者護理資源，實現實時患者參與和個性化數字藥物伴侶。

低意識預計會阻礙市場增長。

然而，阻礙藥物管理系統市場增長的其他因素包括欠發達國家對此類系統的認識不足以及與此類系統相關的高成本。

COVID-19 影響分析

COVID-19 大流行對經濟產生了積極影響。 由於大流行，世界各地的醫療機構都承受著巨大的壓力。 實施封鎖和社會隔離以防止疾病傳播。 慢性病患者正在遭受痛苦，因為他們無法使用醫療設施進行常規治療和藥物分發。 得益於零售藥店，這些人可以快速輕鬆地獲得幫助。 在 COVID-19 大流行期間提供藥物時，社區藥劑師致力於為訪問其設施的客戶預防、識別和解決藥物問題。

區域藥劑師非常適合這個職位，因為他們是 COVID-19 大流行期間最平易近人的醫療保健專業人員群體。 社區藥師可以解決不合理用藥的突出問題，促進普通大眾和慢性病患者等特殊人群的合理用藥。 在大流行期間，社區藥劑師參與管理慢性健康狀況並促進這些中心的藥物依從性對於緩解世界上過度勞累的醫療保健系統的壓力至關重要。

內容

第 1 章研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 市場進入者推出產品有助於市場發展
      • 越來越多的醫院在創新技術上投入更多資金
    • 阻止因素：
      • 認知度低預計會阻礙市場增長
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第 6 章 COVID-19 分析

  • 市場上 COVID-19 的分析
    • 在 COVID-19 市場情景之前
    • 當前的 COVID-19 市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第 7 章按軟件類型分類

  • 計算機訂單輸入 (CPOE)
    • 臨床決策支持系統 (CDSS)
    • 電子藥品管理記錄
    • 庫存管理系統
    • 其他

第八章服務

  • 醫學分析服務
  • ADE 監控服務
  • 護理點驗證服務

第九章運輸方式

  • 基於網絡
  • 基於雲
  • 本地

第 10 章最終用戶

  • 醫院
  • 藥房
  • 其他

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 知名大公司名單

第13章公司簡介

  • 通用電氣醫療
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • QUALCOMM Incorporated
  • Omnicell, Inc
  • Talyst, LLC
  • Allscripts Healthcare Solutions Inc.
  • ARxIUM
  • Becton Dickinson and Company
  • Cerner Corporation
  • QuadraMed Affinity Corporation
  • McKesson Corporation

第14章 DataM

簡介目錄
Product Code: HCIT1783

Market Overview

The global medication management market size was valued at US$ 2,469.34 million in 2022 and is estimated to reach US$ 10,129.43 million by 2030, growing at a CAGR of 20.00% during the forecast period (2023-2030).

Medication management is a strategy for communicating with patients and caregivers to create a precise and thorough inventory of all the medications consumed. A complete and accurate prescription list is the first step in solving medication reconciliation and management problems. These tools can also help identify behaviors that may put patients at risk for drug-related adverse events, such as overdosing or underdosing on medications, forgetting to take them, or other important contextual factors that impede adherence.

Market Dynamics

The major factors driving the global Medication management market the product launches by industry participants are aiding the market to develop, the growing number of hospitals putting more money into innovative technology and the industry is anticipated to grow quickly as the number of prescriptions worldwide increases.

Product launches by industry participants are aiding the market's growth.

Increased investments in the launch of new products, improved healthcare process management, and reduced prescription error is predicted to drive market expansion.

For instance, in January 2023, Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), one of the China operating entities with which the Company consolidates the financial results through certain contractual arrangements, launched the Medication Management Assistance Mini Program on WeChat (the "Program") to help cancer patients manage a variety of issues. Zhongchao Inc., a platform-based internet technology company that provides services to patients with oncology and other serious diseases, made the announcement. To help cancer patients navigate and overcome pharmaceutical problems, Zhongxin established the Program.

And in November 2020, the Boston, Massachusetts-based digital therapeutics companion platform Medisafe has announced the immediate implementation of its innovative Medisafe Maestro platform. This state-of-the-art system orchestrates medication adherence journeys with precision and speed while creating personalized patient care resources that are provided via a digital drug companion. Medisafe provides the pharmaceutical industry with digital patient care resources through its integrated Care Connector, which results in real-time patient involvement and personalized digital drug companions.

Lack of awareness is expected to hamper the market's growth.

However, other factors impeding the growth of the medication management system market include limited awareness of such systems in underdeveloped nations and greater costs related to such systems.

COVID-19 Impact Analysis

The COVID-19 pandemic had a positive impact on the economy. Medical facilities all over the world are under a great deal of stress as a result of the pandemic. To avoid the illness from spreading, lockdowns and social isolation were implemented. Patients with chronic illnesses who could not access healthcare facilities for routine treatment and medication distribution suffered. Thanks to retail pharmacies, these people may get help quickly and easily. Community pharmacists will concentrate on preventing, identifying, and resolving drug therapy difficulties for clients coming to their facility when delivering pharmaceutical care during the COVID-19 pandemic.

Because they are the most approachable group of healthcare professionals during the COVID-19 pandemic, community pharmacists are well-suited for this position. They can address the serious problems of inappropriate medication use and promote rational medication use to members of the general public and special populations like patients with chronic illnesses. Community pharmacists' participation in these centers' management of chronic health conditions and promotion of medication adherence during the pandemic was crucial in easing the pressure on the world's overworked healthcare systems.

Segment Analysis

The medication analytic services segment is expected to grow at the fastest CAGR during the forecast period (2022-2030)

The service segment is the highest market holder in the global Medication management market. Data analytics is the practice of examining unprocessed datasets for patterns, conclusions, and process improvements. Analytics in the healthcare industry uses both present and historical data to generate macro and micro insights that support patient and Company decision-making. Due to the leading players, the Medication Analytic Services segment leads the market. The companies introduce new products and make them easily accessible to customers.

For instance, in July 2021, LGM Pharma announced that it would provide pharmaceutical developers, manufacturers, and compounding pharmacies with contract analytical testing and stability services. The business currently provides analytical services as a component of its integrated contract development and manufacturing (CDMO) operations, but it is now making its facilities and staff available as a stand-alone contract service.

Additionally in June 2022, With the help of data analytics and artificial intelligence, MetroMedi, the fastest-growing online pharmacy and e-health and wellness retailer in South India (Hyderabad), has introduced health advisory services for their customers' health and wellbeing. Data analytics can benefit every facet of patient care and operational management in the healthcare industry. It aids in boosting disease prevention, enhancing clinical care delivery, and assessing the efficacy of various treatment methods.

And in January 2023, Amazon is increasing its healthcare business by launching a prescription drug discount program. The retail behemoth announced Tuesday that it would introduce RxPass, a subscription service for Prime subscribers. According to Amazon, customers will pay USD 5 per month to fill as many prescriptions as they require from a list of approximately 50 generic pharmaceuticals, which are typically less expensive equivalents of name-brand drugs.

Geographical Analysis

North America holds the largest market share in the global Medication management market.

North America dominates the global Medication management market primarily due to factors like the presence of major companies, the high prevalence of chronic diseases in the area, and the well-established healthcare infrastructure are only a few of the major factors responsible for the market's growth. North America dominates the global medication management market due to the widespread use of IT in healthcare, technological improvements, and the prevalence of infectious and chronic diseases. The increase in prescriptions is one of the main factors contributing to the region's dominance.

Contributing variables include multiple small- and medium-sized businesses that offer medication management systems to different hospitals and pharmacies, a high familiarity with new technology, and a need for primary care physicians.

For instance, in March 2022, Hamilton Beach Brands, Inc. and HealthBeacon plc introduced the Smart Sharps Bin Injection Care Management System in the US. The Smart Sharps Bin tracks injection compliance, provides smart medication management reminders, and provides live customer assistance around-the-clock and safe and convenient syringe disposal through the United States Postal Service's approved mail-back Program. Such product launches in the area are likely to support the growth of the medication management system in North America throughout the anticipated time frame.

Competitive Landscape

The Medication management market is moderately competitive with local and global companies' presence. GE Healthcare, QUALCOMM Incorporated, Omnicell, Inc, Talyst, LLC, Allscripts Healthcare Solutions Inc., ARxIUM, Becton Dickinson and Company, Cerner Corporation, QuadraMed Affinity Corporation, McKesson Corporation and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in August 2022, CareDx Inc.,announced the launch of AlloHome, a pan-organ patient monitoring tool that can gather health data while a patient is at home and is accessible on the AlloCare app, has recently been introduced. Patients who use AlloHome get Bluetooth gadgets, such a blood pressure cuff and a glucose meter, that immediately pair with a smart hub in the house. Data is also sent to the patient's AlloCare app.

Omnicell, Inc.

Overview: Omnicell, Inc., a major provider of healthcare technology, has its corporate headquarters in Mountain View, California. In addition to automated solutions for handling prescriptions in hospitals and other healthcare facilities, it also develops software for patient engagement and medication adherence packaging. Under the brand names Omnicell and EnlivenHealth, it sells its products.

Product Portfolio:

Omnicell's Point of Care: Eliminate nurse countbacks with the Controlled Substance Dispenser for greater efficiency and inventory accuracy. Remotely preselect medications directly from the EHR for fast retrieval at Omnicell ADC.

The global Medication management market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Product launches by industry participants are aiding the market to develop.
      • 4.1.1.2. The growing number of hospitals putting more money into innovative technology.
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness is expected to hamper the market's growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Software Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 7.1.2. Market Attractiveness Index, By Software Type
  • 7.2. Computerized Physician Order Entry (CPOE)
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
    • 7.2.3. Clinical Decision Support System (CDSS)
    • 7.2.4. Electronic Medication Administration Records
    • 7.2.5. Inventory Management System
    • 7.2.6. Others

8. By Service

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 8.1.2. Market Attractiveness Index, By Service
  • 8.2. Medication Analytic Services
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. ADE Surveillance Services
  • 8.4. Point of Care Verification Services

9. By Mode of Delivery

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 9.1.2. Market Attractiveness Index, By Mode of Delivery
  • 9.2. Web-based
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Cloud-based
  • 9.4. On-premise

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 10.3. Pharmacies
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. GE Healthcare
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. QUALCOMM Incorporated
  • 13.3. Omnicell, Inc
  • 13.4. Talyst, LLC
  • 13.5. Allscripts Healthcare Solutions Inc.
  • 13.6. ARxIUM
  • 13.7. Becton Dickinson and Company
  • 13.8. Cerner Corporation
  • 13.9. QuadraMed Affinity Corporation
  • 13.10. McKesson Corporation

LIST NOT EXHAUSTIVE

14. Global Medication management Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Application
  • 14.3. Contact Us